SubsidieMeestersEmpowering Radiologists in Cancer Diagnostics with Artificial Intelligence
Better Medicine AI automates repetitive tasks in cancer CT scan analysis, reducing radiologist workload by 40-60% to improve diagnostic accuracy and address the radiologist shortage.
Projectdetails
Introduction
There is already a major shortage of radiologists who analyze CT scans for cancer diagnostics. Radiologists spend too much time on manual and repetitive tasks, such as manually measuring lesions, using inadequate tooling. As the incidence of cancer is expected to grow 27.4% over the next 10 years (according to WHO), the pressure on radiologists will only increase, leading to misdiagnosis or delay in diagnosis with potentially fatal consequences.
Solution Overview
With Better Medicine Artificial Intelligence, the time radiologists spend on interpreting cancer-related CT scans is reduced by 40-60% by automating a range of repetitive tasks to significantly streamline workflows.
Benefits
- We help reduce the shortage of radiologists.
- We save lives with timely and accurate diagnostics.
Unique Features
Our solution is the first AI-powered tool for radiologists that takes the full-body approach and enables dynamic assessment of tumors, overcoming the biggest shortcomings of current offerings on the market.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.875 |
| Totale projectbegroting | € 3.571.250 |
Tijdlijn
| Startdatum | 1-1-2024 |
| Einddatum | 31-12-2025 |
| Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- BETTER MEDICINE OUpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
AI-based clinical software for fully automated Cardiac Magnetic Resonance reportingAI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes. | EIC Accelerator | € 1.753.842 | 2022 | Details |
Precision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patientsDoMore Dx offers innovative diagnostics software using deep learning on cancer tissue images to personalize chemotherapy decisions, potentially saving 250,000 patients and 4 billion EUR annually. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Facilitating personalised Lung Treatment Decisions through a Deeptech AI Clinical Decision Support SystemThirona's LungQ-Care project aims to develop an AI-driven clinical decision support system to enhance personalized lung treatment and streamline thoracic imaging analysis. | EIC Accelerator | € 2.499.999 | 2023 | Details |
AI-driven cardiac ultrasound analysisLigence is developing an AI-driven tool to automate heart ultrasound image analysis, enhancing accessibility, accuracy, and speed of diagnosis in healthcare settings. | EIC Accelerator | € 2.500.000 | 2022 | Details |
SWAN: Blitzscaling the early detection of skin cancerSwan offers rapid, full-body dermoscopic skin cancer detection using advanced AI and imaging technologies, enhancing early diagnosis and treatment accessibility for all stakeholders. | EIC Accelerator | € 2.500.000 | 2022 | Details |
AI-based clinical software for fully automated Cardiac Magnetic Resonance reporting
AI4MedImaging is developing AI4CMR.Plus, a revolutionary software for automated cardiac assessment via CMR, aiming for a 2025 launch to enhance CVD diagnosis and improve patient outcomes.
Precision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patients
DoMore Dx offers innovative diagnostics software using deep learning on cancer tissue images to personalize chemotherapy decisions, potentially saving 250,000 patients and 4 billion EUR annually.
Facilitating personalised Lung Treatment Decisions through a Deeptech AI Clinical Decision Support System
Thirona's LungQ-Care project aims to develop an AI-driven clinical decision support system to enhance personalized lung treatment and streamline thoracic imaging analysis.
AI-driven cardiac ultrasound analysis
Ligence is developing an AI-driven tool to automate heart ultrasound image analysis, enhancing accessibility, accuracy, and speed of diagnosis in healthcare settings.
SWAN: Blitzscaling the early detection of skin cancer
Swan offers rapid, full-body dermoscopic skin cancer detection using advanced AI and imaging technologies, enhancing early diagnosis and treatment accessibility for all stakeholders.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Artificiële intelligentie voor Reproduceerbare Analyse van TumorgroeiHet project ontwikkelt AI-software voor betrouwbare tumorweefselanalyse, gericht op CE-certificering voor de Europese markt. | 1.1 - RSO1.1... | € 373.158 | 2023 | Details |
AI-based medical assistant - Herkennen en classificeren van tumoren m.b.v. kunstmatige intelligentieDit project ontwikkelt een geavanceerde beeldherkenningstechnologie voor realtime screening van eiwittypologieën in biopten, om de behandeling van complexe tumoren te verbeteren. | Mkb-innovati... | € 200.000 | 2018 | Details |
AI to predict Cancer metastasis using Ultra-Echo-Sono imagingAI CUrES aims to enhance early diagnosis and pre-emptive therapies for cancer metastasis by utilizing nanosized-contrast agents and AI-driven bioimaging of extracellular vesicles from colorectal tumors. | ERC Proof of... | € 150.000 | 2022 | Details |
Schaalbare AI voor patiënten met pijn op de borstHet project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst. | 1.1 - Het ve... | € 795.688 | 2024 | Details |
Inclusive Artificial Intelligence for Accessible Medical Imaging Across Resource-Limited SettingsAIMIX aims to develop inclusive imaging AI for resource-limited settings, enabling affordable, scalable, and accessible ultrasound screening to reduce global health disparities. | ERC Consolid... | € 2.206.963 | 2023 | Details |
Artificiële intelligentie voor Reproduceerbare Analyse van Tumorgroei
Het project ontwikkelt AI-software voor betrouwbare tumorweefselanalyse, gericht op CE-certificering voor de Europese markt.
AI-based medical assistant - Herkennen en classificeren van tumoren m.b.v. kunstmatige intelligentie
Dit project ontwikkelt een geavanceerde beeldherkenningstechnologie voor realtime screening van eiwittypologieën in biopten, om de behandeling van complexe tumoren te verbeteren.
AI to predict Cancer metastasis using Ultra-Echo-Sono imaging
AI CUrES aims to enhance early diagnosis and pre-emptive therapies for cancer metastasis by utilizing nanosized-contrast agents and AI-driven bioimaging of extracellular vesicles from colorectal tumors.
Schaalbare AI voor patiënten met pijn op de borst
Het project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst.
Inclusive Artificial Intelligence for Accessible Medical Imaging Across Resource-Limited Settings
AIMIX aims to develop inclusive imaging AI for resource-limited settings, enabling affordable, scalable, and accessible ultrasound screening to reduce global health disparities.